SkinBioTherapeutics PLC (LON:SBTX)
—previous session's close (1 Apr 2026) — awaiting today's first price update
Spriggl Score: Weak— sign in to explore; full breakdown with Premium
Last 30 trading days
Spriggl AI Verdict
“A second unexplained leadership change compounds governance concerns despite genuine revenue growth.”
Sign up free to read the full investment thesis, bull case, bear case and what to watch.
About SkinBioTherapeutics PLC
SkinBioTherapeutics plc, a life science company, engages in research and development, and commercialization of technology that harnesses the microbiome for human health in the United Kingdom, the United States, Europe, and internationally. It develops SkinBiotix technology that h…
- Sector:
- Healthcare
- Industry:
- Biotechnology
- Market Cap:
- £25.3M
Recent dividends
No recent dividends recorded.
Get the full Spriggl analysis — free
A free Spriggl account gets you the screener, a watchlist, AI verdicts on our UK coverage and a free full report every day — across SkinBioTherapeutics PLC and 1,700+ UK and US stocks. The full score breakdown and AI analysis come with Premium.
Start free